Bio

Pascal Noth is part of the Private Equity Health and Life business unit, based in Zug. He is a member of the Private Equity Direct Leads Investment Committee, the Private Equity Direct Co-Investments, extension secondaries and direct lead growth investments in Health and Life Investment Committee and led the firm's investments into AMMEGA, Pharmathen, Sterling Pharma, Zabka, HTL and Laboratoires Serb. He has 23 years of industry experience and, prior to joining Partners Group, he was a Partner at Palamon Capital and worked at Goldman Sachs and Monitor Group. Pascal received the EY Entrepreneur of the Year in 2002 and holds an MBA with distinction from INSEAD, France where he received the Roche Fellowship of the Year. He also holds a master’s degree in Medical Neuroscience and Neural Computation from the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland.